Denali Therapeutics
DNLI
#3410
Rank
โ‚ฌ3.18 B
Marketcap
22,11ย โ‚ฌ
Share price
-0.30%
Change (1 day)
10.63%
Change (1 year)

Revenue for Denali Therapeutics (DNLI)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of โ‚ฌ0.29 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Denali Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 โ‚ฌ0.29 B195.7%
2022 โ‚ฌ0.10 B135.33%
2021 โ‚ฌ42.96 M-84.25%
2020 โ‚ฌ0.27 B1045.91%
2019 โ‚ฌ23.81 M-78.91%
2018 โ‚ฌ0.11 B
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.55 BN/A Jersey
โ‚ฌ0.80 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.09 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.79 MN/A๐Ÿ‡ฌ๐Ÿ‡ง UK